WuXi AppTec SVP Richard Soll On China’s Pharma Evolution: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
Soll talks about the transition of China’s top CRO from a preclinical play to an integrated services provider for innovative drug development.